HIV-2 RNA Tests for Diagnostic Use
- Individuals who screen reactive with an HIV-1/2 or HIV-1/2 Ag/Ab immunoassay and are positive for HIV-2 Abs on an FDA-approved supplemental HIV-1/2 Ab-differentiation assay are considered positive for HIV-2 Abs; clinicians should perform a clinical evaluation for HIV-2 infection. (A1)
- Clinicians caring for patients with HIV-2 infection should contact the Wadsworth Center’s Bloodborne Viruses Laboratory at (518) 474-2163 for guidance on HIV-2 viral load monitoring.
